The report "North
American Interventional Cardiology & Peripheral Vascular Devices Market by
Angioplasty Balloon (Plain/Old, Cutting), Stent (Bio absorbable, Drug-Eluting),
Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft -
Forecast to 2018" analyzes and studies the major market drivers,
restraints, and opportunities in the U.S. and Canada.
Browse 108 market data tables and 24 figures spread through 245 pages and in-depth TOC on "North American Peripheral Vascular Devices Market"
Early buyers will receive 10% customization on this report.
This report studies the North American peripheral vascular devices market over the forecast period of 2013 to 2018. Promise for lesser risk of restenosis is expected to spur market growth.
The North American peripheral vascular devices market is expected to
reach $5,947.5 million by 2018, at a CAGR of 2.9% during 2013 to 2018.The
decreasing incidences of coronary angioplasties and the increasing peripheral
intervention procedures have impacted the surgical equipment market
significantly in North America.
Talk to Our Research Analysts for More Info@
The risk of restenosis in angioplasty procedures encourages the
adoption of novel technologies to minimize post-surgical complications. Amongst
various surgical devices, bio absorbable stents were found to be a major
breakthrough in the market. The bio absorbable stents market is expected to
witness a significant CAGR of 62.2% during the forecast period. The success
achieved during the ongoing studies is also anticipated to spur the market
In addition to the next-generation stent, advanced diagnostic catheters such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) catheters are expected to grow at a faster pace in the coming years. Better diagnosis of vascular health as compared to conventional guiding catheters is the major reason behind the significant market growth.
Get The Sample Copy Of This Report:
In the market, retrievable inferior vena cava filter (IVC) occupies a notable market space as it becomes the gold standard for the treatment of DVT/PE in North America. Moreover, reduced risk of long-term post-surgical complication, which is common with permanent IVC filters, is expected to ensure a CAGR of 14.8% during the forecast period.
Analysis of the market dynamics identified the unique nature of the U.S. and Canadian markets. The technology adoption rate in Canada was found to be significantly high in 2013, though the total number of various cardiac procedures was much higher in the U.S. Bio absorbable stents are still under investigational study; however, it is available on a special access basis from Health Canada. Furthermore, angioplasty procedures through femoral route are still prevalent in the U.S. market; whereas, radial route angioplasty procedures gain significant adoption in the Canadian market.
On the contrary, the U.S. market is significantly advanced in terms of required infrastructure as compared to the Canadian market. The Canadian market still lacks adequate number of cardiac facilities and skilled interventionists. Moreover, average waiting time for availing cardiac care is appalling in Canada; such factor is expected to fuel the adoption of advanced minimally invasive techniques in Canada in the coming years.
Analysis of notable players has brought to light that the
market is fairly consolidated with a few leading players. The notable players
of this market include Abbott Laboratories (U.S.), Cordis Corporation (U.S.),
Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), and Covidien,
Browse related reports:
Cardiology Market By Congenital Heart Defect Closure
Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial
Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts
Cardiovascular Information System Market by Applications (Catheterization Lab, Vascular Lab, Echocardiography, Electrocardiography, Electrophysiology), Delivery Mode, End Users (Small, Medium and Large Hospitals) & Components - Forecasts to 2018.
is the world’s No. 2 firm in terms of annually published premium market
research reports. Serving 1700 global fortune enterprises with more than 1200
premium studies in a year, M&M is catering to a multitude of clients across
8 different industrial verticals. We specialize in consulting assignments and
business research across high growth markets, cutting edge technologies and
newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche markets.
The new included chapters on Methodology and Benchmarking presented with high
quality analytical infographics in our reports gives complete visibility of how
the numbers have been arrived and defend the accuracy of the numbers.
MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets